ARTELO BIOSCIENCES, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
ARTELO BIOSCIENCES, INC. (ARTL) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$887 for the 6-month period ending 2018-02-28, per its 10-Q/A filed 2018-05-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-14
- ARTELO BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-02-28 was -$20.00.
- ARTELO BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-11-30 was -$867.00.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month |
|---|---|---|
| 2018-02-28 | -$20.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-05-14 | -$887.00 10-Q/A · filed 2018-05-14 |
| 2017-11-30 | -$867.00 10-Q/A · filed 2018-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |